Blanket Purchase Agreement 36C26120A0009

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

Central Admixture Pharmacy Services, Inc. (CAPS), a provider of compounded sterile preparations and pharmacy services, has been awarded a $6.5 million Blanket Purchase Agreement (BPA) by the Defense Health Agency (DHA). Under this IDV, CAPS will deliver a variety of compounded admixture medicines, total parenteral nutrition, and other sterile pharmaceutical products to support DHA medical programs. The contract has a period of performance through July 14, 2026, with no set-aside designation....

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmedium Services, LLC for specialized compounded intravenous solutions. The potential value of the BPA is $2.5 million. The period of performance is from October 1, 2018 through September 30, 2023. The BPA will facilitate orders for various pharmaceutical supplies to support pharmacy operations at Tripler Army Medical Center in Hawaii. Products included under the BPA are OR syringes, pre-mixed...

The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...

The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...

The Department of Veterans Affairs Veterans Health Administration awarded a single-award blanket purchase agreement to Optum Pharmacy 601, LLC to provide compound pharmacy services. The $120,764.81 BPA is a contingency contract contingent upon continued operations at the East Orange, New Jersey VA medical center laboratory. Optum Pharmacy will deliver compounded pharmaceutical preparations to Veterans Integrated Service Network 2, which coordinates health care services for veterans in parts of...

This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 to Pharmacy Onesource, Inc., a foreign-owned, for-profit organization. The contract, valued at up to $1,750,000, is for the provision of pharmaceutical compounding software over a period ending on September 30, 2026. The BPA and associated task orders provide the VA with access to Pharmacy Onesource's SIMPLIFI 797 medication workflow automation platform, as...

Bayer Healthcare Pharmaceuticals Inc., a subsidiary of global pharmaceutical company Bayer AG, was awarded a single-award Blanket Purchase Agreement valued at $6.8 million by the Department of Veterans Affairs National Acquisition Center on October 6, 2025, with performance through October 5, 2026. This BPA specifically covers two specialized pharmaceutical products: Xofigo (radium Ra 223 dichloride), indicated for prostate cancer treatment, and Adempas, used to treat pulmonary arterial...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company. The $2,500,000 BPA is for the supply of the pharmaceutical drug sodium oxybate and does not utilize any set-asides. Amneal Pharmaceuticals has been awarded several other federal contracts and IDVs, primarily for the provision of specialized pharmaceutical products and services, including a $1,710,320...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Marius Pharmaceuticals LLC, a self-certified small disadvantaged business organized as a limited liability company. The BPA has a ceiling value of $10,000,000 and a period of performance through January 31, 2024. The primary purpose of this BPA is to facilitate the procurement of a specific pharmaceutical product called KYZATREX by the Department of Veterans Affairs (VA) and its...